Recombinant LILRA4 (Daxdilimab Biosimilar) antibody

Catalog No. ABIN7488282

The CHO Cells Monoclonal anti-LILRA4 (Daxdilimab Biosimilar) antibody has been validated for . It is suitable to detect LILRA4 (Daxdilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant LILRA4 (Daxdilimab Biosimilar) antibody (ABIN7488282)

Target: LILRA4 (Daxdilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: CHO Cells

Clonality: Monoclonal

Conjugate: This LILRA4 (Daxdilimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-LILRA4 (Daxdilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Daxdilimab Biosimilar - Anti-LILRA4 mAb

Characteristics: Antibody Type: IgG1?Lambda

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for LILRA4 (Daxdilimab Biosimilar)

Target: LILRA4 (Daxdilimab Biosimilar)

Target Type: Biosimilar

Background: DAXDILIMAB [WHO-DD]?IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUKOCYTE IG-LIKE RECEPTOR A4) (HUMAN MONOCLONAL VIB7734 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIB7734 .LAMBDA.-CHAIN, DIMER, MEDI7734, VIB7734, MEDI-7734, VIB-7734